Desoximetasone, 98.5%

Name: Desoximetasone, 98.5% | 382-67-2
Brand: J&K Chemical
SKU: JK421072_50_MG
Price: 427.0 USD
Availability: OutOfStock

Cat. No JK421072_50_MG

Vendor: J&K Chemical

Product Information

Product Name

Desoximetasone, 98.5%

Brand Name

J&K

Product Number

421072

CAS

382-67-2

Molecular Formula

C22H29FO4

Molecular Weight

376.46

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

5311067

Properties

Melting Point

216-218

References Data Source From Pubchem

Koebner phenomenon in autoimmune bullous dermatoses: a scoping review of documented cases

Publication Name: Archives of Dermatological Research

Publication Date: 2026-02-26

DOI: 10.1007/s00403-026-04554-2

A rare case of unusual anti-tuberculosis drug reaction in disseminated tuberculosis with pre-existing Multisystem Inflammatory Syndrome in Children (MIS-C)

Publication Name: BMC Infectious Diseases

Publication Date: 2026-01-09

DOI: 10.1186/s12879-026-12514-4

Mechanistic Modelling of Lidocaine and Prilocaine Absorption from EMLA Cream upon Topical Application using Physiologically Based Pharmacokinetic Modelling

Publication Name: AAPS PharmSciTech

Publication Date: 2025-12-17

DOI: 10.1208/s12249-025-03232-2

Mycosis fungoides with Sézary syndrome mimicking erythrodermic drug eruption

Publication Name: memo - Magazine of European Medical Oncology

Publication Date: 2025-11-14

DOI: 10.1007/s12254-025-01086-9

The Impact of Using Measured In Vitro Data to Develop Physiologically Based Pharmacokinetic Models of Dermal Absorption: An IVIVE Case Study

Publication Name: The AAPS Journal

Publication Date: 2025-09-02

DOI: 10.1208/s12248-025-01113-x

Desoximetasone, 98.5%

Product Information

General Information

Properties

References Data Source From Pubchem

Koebner phenomenon in autoimmune bullous dermatoses: a scoping review of documented cases

A rare case of unusual anti-tuberculosis drug reaction in disseminated tuberculosis with pre-existing Multisystem Inflammatory Syndrome in Children (MIS-C)

Mechanistic Modelling of Lidocaine and Prilocaine Absorption from EMLA Cream upon Topical Application using Physiologically Based Pharmacokinetic Modelling

Mycosis fungoides with Sézary syndrome mimicking erythrodermic drug eruption

The Impact of Using Measured In Vitro Data to Develop Physiologically Based Pharmacokinetic Models of Dermal Absorption: An IVIVE Case Study